These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11508786)

  • 1. Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.
    Sartorio A; Palmieri E; Vangeli V; Conte G; Narici M; Faglia G
    J Endocrinol Invest; 2001; 24(7):515-21. PubMed ID: 11508786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen.
    Guzzaloni G; Grugni G; Morabito F
    J Endocrinol Invest; 1999 May; 22(5):360-8. PubMed ID: 10401710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels.
    Bellone S; Corneli G; Bellone J; Baffoni C; Rovere S; de Sanctis C; Bona G; Ghigo E; Aimaretti G
    J Endocrinol Invest; 2002 May; 25(5):426-30. PubMed ID: 12035938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency.
    Hilczer M; Smyczyńska J; Lewiński A
    Neuro Endocrinol Lett; 2006; 27(1-2):149-52. PubMed ID: 16648787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood.
    Svensson J; Johannsson G; Iranmanesh A; Albertsson-Wikland K; Veldhuis JD; Bengtsson BA
    Eur J Endocrinol; 2006 Jul; 155(1):91-9. PubMed ID: 16793954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
    Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
    J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.